PAHC
PAHC
NASDAQ · Pharmaceuticals

Phibro Animal Health Corp-A

$50.76
-1.62 (-3.09%)
As of Mar 22, 10:03 PM ET ·
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Buy 1 11%
Hold 4 44%
Sell 4 44%
Price Target
Analyst Price Target +112.2% upside
Low Target $71.95
Average Target $107.71
High Target $157.72
Current Price $50.76
Current
$50.76
Target
$107.71
$71.95 $107.71 avg $157.72
Scenario Analysis
Bear Case
$71.95
41.7%
Low target
Base Case
$107.71
+112.2%
Avg target
Bull Case
$157.72
+210.7%
High target
Risk/Reward
5.0x
Highly favorable
Price in Context
52-Week High
$56.30
-9.8% from high
52-Week Low
$16.16
+214.1% from low
50-Day SMA
$42.00
+20.9% vs SMA
200-Day SMA
$35.40
+43.4% vs SMA
RSI (14)
80.2
Overbought
Target vs 52W High
$107.71
+91.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%